Recent success in using 68Ga/68Ge generator generator-based 68Ga-DOTATATE and 68Ga-PSMA-11 for routine diagnosis of neuroendocrine and prostate cancer, respectively, would likely to increase the acceptance of 68Ga tracers for routine clinical application. This evidence concerns the gene FOLH1 and Familial prostate cancer.